Michael T. Zelasky
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Bacterial Identification and Susceptibility Testing 2
-
- Antimicrobial Resistance in Staphylococcus 3
- Co-authors
- Robert C. HolmanMichael W. DunneSailaja PuttaguntaDainis KrieviņšPhilip GiordanoJames BaldassarreJames W. BuehlerRobert S. Janssen
- Journals
- Clinical Infectious Diseases (4 papers)American Journal of Public Health (2 papers)Neurology (2 papers)Open Forum Infectious Diseases (2 papers)Clinical Microbiology and Infection (1 paper)
- Partner nations
- United StatesLatvia
In The Last Decade
Michael T. Zelasky
13 papers receiving 527 citations
Peers
Comparison fields: 5 of 73
- Applied Microbiology and Biotechnology 53
- Molecular Medicine 90
- Clinical Biochemistry 93
- Infectious Diseases 249
- Pharmacology 107
Countries citing papers authored by Michael T. Zelasky
This map shows the geographic impact of Michael T. Zelasky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael T. Zelasky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael T. Zelasky more than expected).
Fields of papers citing papers by Michael T. Zelasky
This network shows the impact of papers produced by Michael T. Zelasky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael T. Zelasky. The network helps show where Michael T. Zelasky may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael T. Zelasky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 6 | |
| 2 | 2022 | 24 | |
| 3 | 2022 | 25 | |
| 4 | 2020 | 11 | |
| 5 | 2015 | 173 | |
| 6 | 2015 | 4 | |
| 7 | 1999 | 72 | |
| 8 | 1998 | 49 | |
| 9 | 1992 | 1 | |
| 10 | 1991 | 92 | |
| 11 | Recombinant human granulocyte-macrophage colony-stimulating factor promotes megakaryocyte maturation in nonhuman primates. | 1991 | 22 |
| 12 | 1990 | 9 | |
| 13 | 1989 | 64 |
About Michael T. Zelasky
Michael T. Zelasky is a scholar working on Clinical Biochemistry, Infectious Diseases, Hematology, Pharmacology and Molecular Medicine, having authored 13 papers that have together received 552 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (4 papers), Antimicrobial Resistance in Staphylococcus (3 papers), Urinary Tract Infections Management (3 papers), Pediatric Urology and Nephrology Studies (2 papers), Bacterial Identification and Susceptibility Testing (2 papers), Blood properties and coagulation (1 paper), T-cell and Retrovirus Studies (1 paper) and Salmonella and Campylobacter epidemiology (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (53 citations), Molecular Medicine (90 citations), Clinical Biochemistry (93 citations), Infectious Diseases (249 citations) and Pharmacology (107 citations). Michael T. Zelasky has collaborated with scholars based in United States and Latvia. Frequent co-authors include Robert C. Holman, Michael W. Dunne, Sailaja Puttagunta, Dainis Krieviņš, Philip Giordano, James Baldassarre, James W. Buehler, Robert S. Janssen, W. Craig Hooper and Anita Das. Their work appears in journals such as Clinical Infectious Diseases, American Journal of Public Health, Neurology, Open Forum Infectious Diseases and Clinical Microbiology and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.